T. Norberg

发表

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.

L. Holmberg, H. Nordgren, S. Klaar, 2001, Cancer research.

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.

L. Holmberg, J. Bergh, H. Nordgren, 2001, Cancer research.

Results from a Breast Cancer Cohort − − Mutation Frequency during Tumor Progression p 53 Increased Updated

L. Holmberg, J. Bergh, H. Nordgren, 2001 .

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors

J. Bergh, M. Inganäs, T. Norberg, 1998, International journal of cancer.

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

L. Holmberg, J. Bergh, M. Inganäs, 1996, Journal of the National Cancer Institute.

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings.

L. Holmberg, J. Bergh, M. Inganäs, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53.

L. Holmberg, J. Bergh, H. Nordgren, 1996, Acta oncologica.

Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers.

T. Lindahl, S. Klaar, T. Norberg, 2001, Clinical chemistry.

Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: Analysis of loss of heterozygosity

L. Holmberg, J. Bergh, J. Smeds, 2005, Acta oncologica.

Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.

T. Norberg, U. Ringborg, A. Platz, 1996, British Journal of Cancer.

Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets.

J. Bergh, F. Pontén, M. Uhlén, 1998, Clinical chemistry.

Sequencing of the tumor suppressor gene TP 53.

J. Bergh, T. Norberg, B. Linderholm, 2006, Methods in molecular medicine.

Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo-and a CysHis domain

Stefan Thor, T. Norberg, S. Thor, 1990, Nature.

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

L. Holmberg, J. Bergh, A. Lindgren, 1995, Nature Medicine.

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

T. Lindahl, L. Holmberg, J. Bergh, 2003, Carcinogenesis.

Response on p53

L. Holmberg, J. Bergh, M. Inganäs, 1996 .